跳至主要内容
临床试验/NCT07168265
NCT07168265已完成不适用

The Effects of Androgen Replacement Therapy on Tear Osmolarity and Ocular Surface Parameters in Androgen Deficiency

Neon Hospital1 个研究点 分布在 1 个国家目标入组 77 人开始时间: 2020年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
77
试验地点
1
主要终点
Tear Osmolarity in mOsm/L

研究概览

简要总结

Objective: To evaluate tear osmolarity and ocular surface findings in men with androgen deficiency (AD) and assess changes after androgen replacement therapy (ART).

Design: A prospective interventional study. Participants and Methods Right eyes of 77 male participants were evaluated in this study. Serum total testosterone level were measured, and participants were categorized as AD group (testicular hypofunction, n=37, testosterone level <231 ng/dL) and control group (healthy controls, n=40, testosterone level >346 ng/dL). The parameters including Aging Male Symptoms Scale(AMS), OSDI scores, Meibomian Gland Dysfunction- Grading System(MGD-GS) scores, corneal staining, tear break-up time(TBUT), Schirmer I/II tests, tear osmolarity, the depth (TMD), the height (TMH) and the area (TMA) of inferior tear meniscus were investigated. AD group received intramuscular testosterone every two weeks.

Main Outcome Measures: The changes in the ocular surface parameters were investigated during the ART while comparing the values of these parameters between the AD and control groups at baseline, 6th and 18th weeks of the treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Androgen deficiency

排除标准

  • •having any ocular disease, history of surgery, drop use

研究组 & 干预措施

testosterone

Other

干预措施: androgen replacement therapy (Drug)

结局指标

主要结局

Tear Osmolarity in mOsm/L

时间窗: 5 months

Tear osmolarity was measured by TearLab device in patients. The changes in the tear osmolarity were investigated during the ART while comparing the values of these parameters between the AD and control groups at baseline, 6th and 18th weeks of the treatment.

Schirmer Test in mm

时间窗: 5 months

Schirmer Test is applied by Schirmer tear paper after anesthesic drop administration into the eye.

Tear break-up time (TBUT) in sec

时间窗: 5 months

TBUT is measured by ophthalmologist after application of fluorecein dye.

MGD-GS score in number

时间窗: 5 months

MGD-GS score was performed by ophthalmolgist using biomicroscopy

Questionary Scoring in number

时间窗: 5 months

AMS and OSDI scoring charts were completed by the participants.

Optical Coherence Tomography findings: TMH, TMA, and TMD in microns

时间窗: 5 months

Tear meniscus height (TMH), area (TMA), and depth (TMD) were measured by Optical coherence tomography in each participants.

次要结局

未报告次要终点

研究者

发起方
Neon Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验